Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Invacare Falls Most in 27 Years on Possible Work Suspension

Don't Miss Out —
Follow us on:

Dec. 8 (Bloomberg) -- Invacare Corp., maker of home and long-term care medical products, plunged the most in 27 years after saying U.S. regulators proposed suspending some operations at its headquarters and a wheelchair plant in Ohio.

Invacare sank 29 percent to $14.70 at the close of trading, the biggest single-day decline since Dec. 27, 1984. The Food and Drug Administration proposed a consent decree requiring the work shutdown based on previously disclosed violations found during inspections, the Elyria, Ohio-based company said in a statement. Invacare said it intends to enter into talks with the FDA on the decree.

Operations wouldn’t resume until the FDA concludes Invacare is in compliance, Invacare said. The company said it’s tried to improve compliance processes in the past year with the help of outside medical device consultants.

“Invacare is committed to full compliance with FDA regulations, and it intends to work cooperatively with the FDA to resolve the agency’s concerns,” according to the statement.

To contact the reporter on this story: Anna Edney in Washington at aedney@bloomberg.net.

To contact the editor responsible for this story: Adriel Bettelheim at abettelheim@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.